Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
2 trials
Recent
Start date
Enrollment
Interventional
×
Liver Neoplasms
×
Immune Checkpoint Inhibitors
×
Clear all
Filters
3
NCT05497453
2025-02-03
MYCHELANGELO I
Omega Therapeutics
Phase 1/2
Terminated
24 enrolled
NCT05322187
2022-04-11
sPLENTY-pc
RenJi Hospital
Phase 2/3
Unknown
15 enrolled